Percheron Therapeutics Limited
Percheron Therapeutics Limited
Your view on PER.AX
Overview
What the company does, where it operates, and who runs it.
About Percheron Therapeutics Limited
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- James Garner
- Headquarters
- L30, Collins Place, Melbourne, VIC, AU
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- James Garner
- Headquarters
- L30, Collins Place, Melbourne, VIC, AU
Percheron Therapeutics Limited, an Australian enterprise established in 2000 with its headquarters in Melbourne, is dedicated to the research and development of groundbreaking antisense pharmaceuticals. Formerly known as Antisense Therapeutics Limited until its name change in December 2023, the company holds a promising product portfolio.
This includes ATL1102, an antisense inhibitor designed to target CD49d, which is currently undergoing Phase IIa clinical trials for the treatment of various inflammatory and muscular conditions such as Duchenne Muscular Dystrophy, Limb Girdle Muscular Dystrophy R2, multiple sclerosis, and asthma.
Another key asset is Atesidorsen (ATL1103), an oligonucleotide that has finished Phase II clinical trials. Atesidorsen functions by blocking the growth hormone receptor, aiming to lower blood concentrations of insulin-like growth factor-I (IGF-I) and thereby address illnesses linked to an overabundance of growth hormone activity.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Percheron Therapeutics Limited. Starting points for Percheron Therapeutics Limited: beta 1.03 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Percheron Therapeutics Limited. Percheron Therapeutics Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Percheron Therapeutics Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Percheron Therapeutics Limited. Percheron Therapeutics Limited has reported as a listed company since 2023. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| HMPQHempAmericana, Inc | Healthcare | OTC | $291,753 | ||
| HPMMHemp Naturals, Inc. | Healthcare | OTC | $174,630 | ||
| CRDLCardiol Therapeutics Inc. | Healthcare | NASDAQ | $104.1M | ||
| CRDL.TOCardiol Therapeutics Inc. | Healthcare | TSX | $147.2M | ||
| CRFTFBC Craft Supply Co. Ltd. | Healthcare | OTC | $23 | ||
| CRLBFCresco Labs Inc. | Healthcare | OTC | $350.4M | ||
| CRONCronos Group Inc. | Healthcare | NASDAQ | $1.1B | ||
| CRON.TOCronos Group Inc. | Healthcare | TSX | $1.6B | ||
| CRYMCryomass Technologies Inc. | Healthcare | OTC | $47,432 | ||
| CSTFCuraScientific Corp | Healthcare | OTC | $377,345 | ||
| CSWYFChina Shineway Pharmaceutical Group Limited | Healthcare | OTC | $758.4M | ||
| CSWYYChina Shineway Pharmaceutical Group Limited | Healthcare | OTC | $36.4M | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Percheron Therapeutics Limited. Coverage tracks Percheron Therapeutics Limited within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Percheron Therapeutics Limited.